Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itulazax for birch-related pollen-food syndrome in adults
NL-OMON53964Recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Mar 2023
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of allergenic extract of birch in allergic rhinitis (AR), Pollen Food Allergy Syndrome (PFAS) and food allergy, sponsored by University Medical Center Utrecht. Primary endpoint: Food allergy-related quality of life. Started Mar 2023; status: recruiting.
02
Drugs
allergenic extract of birch
03
Conditions
allergic rhinitis (AR)Pollen Food Allergy Syndrome (PFAS)food allergy
Beyond the preview
Go deeper on NL-OMON53964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON53964.